KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Other financing activities (2016 - 2025)

Unitedhealth (UNH) has disclosed Other financing activities for 17 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 468.26% to $2.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $366.0 million, a 122.25% increase, with the full-year FY2025 number at $366.0 million, up 122.25% from a year prior.
  • Other financing activities was $2.2 billion for Q4 2025 at Unitedhealth, up from -$1.8 billion in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $5.1 billion in Q1 2022 to a low of -$7.4 billion in Q3 2022.
  • A 5-year average of -$202.0 million and a median of -$574.5 million in 2024 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: plummeted 16870.0% in 2021, then soared 661.71% in 2023.
  • Unitedhealth's Other financing activities stood at -$1.7 billion in 2021, then skyrocketed by 81.73% to -$310.0 million in 2022, then plummeted by 725.16% to -$2.6 billion in 2023, then surged by 77.09% to -$586.0 million in 2024, then surged by 468.26% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for UNH's Other financing activities are $2.2 billion (Q4 2025), -$1.8 billion (Q3 2025), and -$1.3 billion (Q2 2025).